Quinn Opportunity Partners LLC Acquires New Stake in Ventas, Inc. $VTR

Quinn Opportunity Partners LLC bought a new position in shares of Ventas, Inc. (NYSE:VTR) during the 3rd quarter, HoldingsChannel.com reports. The institutional investor bought 94,000 shares of the real estate investment trust’s stock, valued at approximately $6,579,000.

A number of other institutional investors have also recently added to or reduced their stakes in VTR. NewEdge Advisors LLC increased its position in shares of Ventas by 856.1% during the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock valued at $545,000 after purchasing an additional 7,097 shares during the period. Empowered Funds LLC lifted its holdings in shares of Ventas by 6.8% in the first quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after buying an additional 536 shares during the period. Woodline Partners LP lifted its holdings in shares of Ventas by 46.8% in the first quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after buying an additional 11,739 shares during the period. Focus Partners Wealth boosted its stake in Ventas by 130.4% during the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after buying an additional 12,233 shares in the last quarter. Finally, Allworth Financial LP boosted its stake in Ventas by 126.7% during the second quarter. Allworth Financial LP now owns 7,038 shares of the real estate investment trust’s stock valued at $444,000 after buying an additional 3,933 shares in the last quarter. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Ventas

In other Ventas news, CFO Robert F. Probst sold 29,930 shares of Ventas stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the transaction, the chief financial officer owned 138,434 shares of the company’s stock, valued at $10,694,026.50. The trade was a 17.78% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Carey S. Roberts sold 35,532 shares of the company’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total value of $3,020,220.00. Following the completion of the transaction, the executive vice president owned 72,755 shares in the company, valued at $6,184,175. This represents a 32.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 86,106 shares of company stock valued at $6,931,397 in the last 90 days. 0.80% of the stock is currently owned by corporate insiders.

Ventas Price Performance

VTR opened at $86.68 on Friday. The firm has a market capitalization of $41.17 billion, a P/E ratio of 160.52, a PEG ratio of 2.10 and a beta of 0.73. The stock has a fifty day moving average of $81.46 and a 200-day moving average of $76.33. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03. Ventas, Inc. has a 12-month low of $60.15 and a 12-month high of $87.87.

Ventas (NYSE:VTR) last issued its quarterly earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). The business had revenue of ($1,229.71) million for the quarter, compared to analysts’ expectations of $1.53 billion. Ventas had a net margin of 4.31% and a return on equity of 2.09%. The business’s quarterly revenue was up 21.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.81 EPS. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Equities analysts forecast that Ventas, Inc. will post 3.4 EPS for the current fiscal year.

Ventas Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Tuesday, March 31st. This is a boost from Ventas’s previous quarterly dividend of $0.48. Ventas’s dividend payout ratio is 355.56%.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Royal Bank Of Canada boosted their price target on shares of Ventas from $83.00 to $91.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 10th. Wells Fargo & Company raised their price objective on shares of Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $93.00 price objective on shares of Ventas in a research note on Monday, December 15th. KeyCorp boosted their target price on shares of Ventas from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Finally, Mizuho increased their target price on shares of Ventas from $87.00 to $94.00 and gave the company an “outperform” rating in a research note on Wednesday, March 4th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $89.00.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.